PureHealth profit rises 14.1% to AED 1.8 billion in 9 months of 2026

Key Facts

PureHealth said net profit rose 14.1% year on year to AED 1.8 billion in the nine months ended Sept. 30, 2026, as profit grew faster than revenue and the operating margin improved. Group revenue increased 11.5% to AED 22.4 billion during the period. Earnings before interest, taxes, depreciation and amortization rose 20.4% to AED 4.2 billion. The margin on that measure widened to 18.6%, from 17.3% in the year-earlier period. International operations and insurance, along with growth in patient volumes in several markets, shaped the group’s performance during the period.

International operations accounted for about 33% of group revenue, while international healthcare revenue rose 53% to AED 7.3 billion. The segment’s operating profit, measured by EBITDA, increased 63% to AED 1.6 billion. The company attributed part of the growth to the consolidation of Hellenic Healthcare Group’s results in Greece and Cyprus, which contributed AED 2.3 billion in revenue. In the UK, Circle Health Group revenue rose 5.3% year on year. Chairman Kamal Al Mazemi said the integration of the Greek and Cypriot group strengthened PureHealth’s position in both markets, while developing Circle expanded its presence in the UK.

Hellenic Healthcare Group recorded a 6% increase in patient volumes, driven mainly by outpatient activity. Circle’s growth, the company said, came as its activity shifted toward higher-acuity inpatient cases. In the UAE, outpatient volumes rose 9% and inpatient volumes increased 13% year on year during the nine months. Operating capacity stood at 3,543 beds, compared with 3,433 in the year-earlier period, while bed occupancy rose to 76%. The indicators show increased use of operating capacity alongside an expansion in bed numbers, while reported domestic revenue diverged from activity trends following accounting adjustments and operational factors cited by the company.

Reported healthcare revenue in the UAE was AED 8.7 billion, down 9.2% from the year-earlier period. PureHealth attributed the decline to the timing of revenue recognition for the unified procurement program, internal revenue eliminations and lower patient activity in the first quarter. On an adjusted basis, the company said healthcare revenue rose 6% to AED 10.1 billion. The difference between the two figures means the adjusted comparison excludes the effects of factors that affected reported revenue, according to the company’s explanation. International and insurance revenue, meanwhile, increased, taking overall group growth above the growth in reported UAE healthcare revenue.

In insurance, revenue rose 11.7% to AED 6.4 billion, supported by policy renewals, pricing discipline and growth in new business. Gross written premiums increased 14% to AED 6.8 billion. The number of insured members rose 2% to about 3.4 million, while the number of health claims processed increased 6% to 43.2 million. Daman’s net profit was AED 667 million, up 3.9% year on year. PureHealth said insurance growth came alongside policy renewals and new business growth, while the volume of processed claims expanded in parallel with the increase in insured members.

Kamal Al Mazemi said the period’s performance reflected a strategy to build a more diversified healthcare group with a growing international presence. He added that the group’s priority was to build on its international expansion through disciplined investment and continued development of its healthcare portfolio. The company expects international healthcare operations to remain a key growth driver as the integration of Hellenic Healthcare Group matures. It also pointed to continued development of higher-acuity services at Circle Health Group and further disciplined acquisitions to deepen the scope of its business in markets it considers attractive. The company did not specify a timetable for these steps in its results statement.